Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells

about

Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia.Reprogramming Caspase-7 Specificity by Regio-Specific Mutations and Selection Provides Alternate Solutions for Substrate Recognition.

P2860

Q33701925-61515AAC-D195-460D-8CDC-2920B5675EC3 Q37017201-6F821024-DF7F-4A66-A1EA-A5B8CC4F1C7B

P2860

Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells

Item

http://www.wikidata.org/entity/Q36598253

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells

@ast

Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells

@en

type

Item

label

Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells

@ast

Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells

@en

prefLabel

Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells

@ast

Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells

@en

P1476

Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells

@en

P2093

Andrew N Macintyre

http://www.w3.org/2001/XMLSchema#string

Chen Zhao

http://www.w3.org/2001/XMLSchema#string

Chih-Sheng Yang

http://www.w3.org/2001/XMLSchema#string

David A Rizzieri

http://www.w3.org/2001/XMLSchema#string

Jeffrey C Rathmell

http://www.w3.org/2001/XMLSchema#string

Manabu Kurokawa

http://www.w3.org/2001/XMLSchema#string

Michael W Deininger

http://www.w3.org/2001/XMLSchema#string

Sally Kornbluth

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of myeloid leukaemia by the cell-fate determinant Musashi

Dimer formation drives the activation of the cell death protease caspase 9

A unified model for apical caspase activation

Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein.

Comparison of the intrinsic kinase activity and substrate specificity of c-Abl and Bcr-Abl.

Caspase-9 holoenzyme is a specific and optimal procaspase-3 processing machine.

A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9

The molecular biology of chronic myeloid leukemia.

Molecular mechanisms of resistance to STI571 in chronic myeloid leukemia.

Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib.

P304

2300-2305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1206551110

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

Takahiro Ito

Tannishtha Reya

P577

2013-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234157350

http://www.w3.org/2001/XMLSchema#string

P698

23324740

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

3568344

http://www.w3.org/2001/XMLSchema#string

Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells

about

P2860

P2860

Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932